Intercytex to list on AIM to raise £15m

HEALTHCARE company Intercytex Group says it planned to list on London’s junior AIM market to raise £15 million (€21 million), giving it a market capitalisation of around £60.2m (€87.9m).

Intercytex, whose products treat baldness, leg ulcers, and wrinkles, said it would use the funds to develop pipeline products and a broader medicine business. The first share issue is expected on February 1.